| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 10/30/2001 | US6310095 Inhibitors of protein isoprenyl transferases |
| 10/30/2001 | CA2123101C Nitroxyalkylamide derivative |
| 10/25/2001 | WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/25/2001 | WO2001049288A9 Novel compounds and compositions as protease inhibitors |
| 10/25/2001 | CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/24/2001 | EP0840601B1 Thip for treating sleep disorders |
| 10/24/2001 | CN1319092A Benzamide derivatives and their use as cytokine inhibitors |
| 10/24/2001 | CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same |
| 10/23/2001 | US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 10/23/2001 | US6306886 Solid polymorph anticoagulants |
| 10/23/2001 | US6306842 Compound of nonsteroid antiinflammatory agent, spacer and cox-2 inhibitor |
| 10/23/2001 | CA2222657C Intermediates in preparation of new phenylethanolaminomethyltetralins |
| 10/23/2001 | CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
| 10/18/2001 | US20010031878 Novel processes for making- and a new crystalline form of- leflunomide |
| 10/17/2001 | EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 10/17/2001 | EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 10/17/2001 | CN1317965A Compounds having IgE affecting properties |
| 10/16/2001 | US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof. |
| 10/16/2001 | US6303792 Quantitatively determining amount of by-product in solution of desired compound in water and solvent, adding corresponding amount of base, crystallizing and separating desired compound |
| 10/16/2001 | US6303609 Used for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders |
| 10/11/2001 | WO2001074763A1 Aryl and heteroaryl sulfonates |
| 10/11/2001 | WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof |
| 10/11/2001 | DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate |
| 10/11/2001 | DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate |
| 10/11/2001 | CA2404545A1 Aryl and heteroaryl sulfonates |
| 10/10/2001 | EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 10/10/2001 | EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use |
| 10/10/2001 | EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 10/10/2001 | EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 10/10/2001 | EP1140784A2 Ion channel modulating agents |
| 10/10/2001 | EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 10/10/2001 | EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 10/10/2001 | EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 10/10/2001 | EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia |
| 10/10/2001 | EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 10/10/2001 | EP1140079A1 Assays for ligands for nuclear receptors |
| 10/09/2001 | US6300372 3-Cyano-3-(3,4-disubstituted) phenylcyclohexyl-1-carboxylates |
| 10/09/2001 | CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators |
| 10/04/2001 | WO2001072960A2 Il-8 receptor antagonists |
| 10/04/2001 | WO2001021577A3 Melanin concentrating hormone antagonist |
| 10/04/2001 | EP1137647A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/03/2001 | CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates |
| 10/02/2001 | US6297198 Compounds with sulfur groups on isoxazole rings as herbicides |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070672A2 Compounds and methods to treat alzheimer's disease |
| 09/27/2001 | WO2001014576B1 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 09/27/2001 | US20010025105 Anticancer agent; Alzheimer's therapy |
| 09/27/2001 | CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha. |
| 09/27/2001 | CA2401749A1 Compounds and methods to treat alzheimer's disease |
| 09/26/2001 | CN1314813A Novel isoxazolinone antibacterial agent |
| 09/25/2001 | US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure |
| 09/20/2001 | WO2001068585A1 Novel amide compounds |
| 09/20/2001 | WO2001068568A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068033A2 Il-8 receptor antagonists |
| 09/20/2001 | CA2402891A1 Il-8 receptor antagonists |
| 09/19/2001 | CN1313846A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 09/18/2001 | US6291508 Potent ability to bind to retinoic acid receptors thus useful in treating psoriasis and rheumatoid arthritis. |
| 09/18/2001 | US6291505 Pyrazole estrogen receptor agonist and antagonist |
| 09/18/2001 | US6291400 Herbicidal compounds |
| 09/13/2001 | US20010021714 Compounds such as n-(4-bromo-3-methyl-5-isoxazolyl)-2-n-benzylbenzo(b)thiophene-3-sufonamide administered as endothelin peptide receptor antagonists |
| 09/12/2001 | EP1131307A1 Method of producing 2-alkyl-3-(4,5-dihydroisoxazole-3-yl)-halobenzenes |
| 09/12/2001 | EP1131306A2 Isoxazoline fibrinogen receptor antagonists |
| 09/12/2001 | EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 09/11/2001 | US6288098 Administering n-(4-trifluoromethyl)-5-methylisoxazole-4-carboxanilide and n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide |
| 09/11/2001 | US6288071 1-ethylene-2-alkylene-1,4-cyclohexadiene pesticides |
| 09/07/2001 | WO2001064755A2 Isoxazole gegen virale erkrankungen |
| 09/07/2001 | WO2000075107A3 Bradykinin receptor antagonists |
| 09/07/2001 | CA2401405A1 Medicament for viral diseases |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/05/2001 | EP1129082A1 Method and novel intermediate products for producing isoxazolin-3-yl-acylbenzenes |
| 09/05/2001 | CN1311793A Antipicornaviral compounds, their prepn. and use |
| 09/05/2001 | CN1311679A Benzimidazole derivatives as modulators of IgE |
| 09/05/2001 | CN1311675A Compounds having IgE affecting properties |
| 09/04/2001 | USH1992 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses |
| 09/04/2001 | US6284877 Sulfonamide compound and method for its production, metal chelate compound employing the sulfonamide compound, and optical recording medium employing the metal chelate compound |
| 08/30/2001 | WO2001062704A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001016131A3 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 08/30/2001 | WO2001014576A3 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 08/30/2001 | DE10009408A1 Arzneimittel gegen virale Erkrankungen Medicines for viral diseases |
| 08/30/2001 | CA2397234A1 Novel use of phenylheteroalkylamine derivatives |
| 08/29/2001 | CN1070022C 3-hydroxy-5-methylisozazole dihydras and its producing process |
| 08/28/2001 | US6281210 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 08/28/2001 | US6281209 Fungicidal alkoximinomethyldioxazine derivatives |
| 08/23/2001 | WO2001060819A1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 08/23/2001 | WO2001060807A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | WO2001060363A1 A method for synthesizing leflunomide |
| 08/23/2001 | WO2001004116A3 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 08/23/2001 | CA2400290A1 A method for synthesizing leflunomide |
| 08/23/2001 | CA2400021A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/22/2001 | EP1124827A1 3-(substituted phenyl)-5-(substituted heterocyclyl)-1,2,4-triazole compounds |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | CA2000362C Methyl .alpha.-arylacrylates substituted by a heterocyclic radical and their use |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |